TULAVI THERAPEUTICS
Tulavi Therapeutics is a medical device company that develops products to improve surgical care of peripheral nerve injury. The company was founded in 2018 and is headquartered in Los Gatos, California.
TULAVI THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical Device
Founded:
2018-01-01
Address:
Los Gatos, California, United States
Country:
United States
Website Url:
http://www.tulavi.com
Total Employee:
11+
Status:
Active
Contact:
650-248-7914
Email Addresses:
[email protected]
Total Funding:
5.84 M USD
Technology used in webpage:
Euro SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Squarespace Hosted NSONE
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
nference
nference is an Artificial Intelligence (AI)-powered venture creation engine
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Spectrawave
Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.
Spotlight Therapeutics
Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.
Current Advisors List
Current Employees Featured
Founder
Investors List
AMED Ventures
AMED Ventures investment in Venture Round - Tulavi Therapeutics
Official Site Inspections
http://www.tulavi.com Semrush global rank: 7.12 M Semrush visits lastest month: 890
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tulavi Therapeutics"
Tulavi Therapeutics - Crunchbase Company Profile & Funding
Organization. Tulavi Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Tulavi Therapeutics is a medical …See details»
About - Tulavi Therapeutics
Intuitive nerve repair solutions Delivering consistent results About Us We develop tailored nerve care solutions Tulavi’s innovative Adaptive Hydrogel Technology is engineered to support …See details»
Tulavi Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Tulavi Therapeutics, Inc. of Los Gatos, CA. Get the latest business insights from Dun & Bradstreet.See details»
Tulavi Therapeutics Company Profile 2024: Valuation, …
Tulavi Therapeutics General Information Description. Developer of medical technologies designed to transform nerve repair and raise the standard of patient care. The company focuses on designing intuitive nerve repair technology to …See details»
Tulavi Therapeutics - Contacts, Employees, Board Members
Organization. Tulavi Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contacts 6. About. Tulavi Therapeutics has 4 current …See details»
Tulavi Therapeutics - The Org
Tulavi is a biomedical company dedicated to making better nerve care more accessible. By engineering simple, elegant solutions to restore nerve balance, Tulavi strives to ensure that caregivers have access to effective, easy-to-use …See details»
Tulavi Therapeutics - Funding, Financials, Valuation & Investors
Organization. Tulavi Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 3. obfuscated. …See details»
Tulavi Therapeutics - VentureRadar
Tulavi Therapeutics is a privately-held medical device company which is dedicated to developing therapies that directly target the nerves to prevent and/or treat aberrant neural reflex arcs in …See details»
Tulavi Nerve Therapeutics - Company Profile - Tracxn
Dec 5, 2024 Tulavi Nerve Therapeutics. has raised a total funding of $8.5M over 2 rounds. Its first funding round was on Feb 27, 2021. List of recent funding rounds of Tulavi Nerve …See details»
Tulavi Therapeutics | Our Companies | Ascension Ventures
Tulavi Therapeutics is a development-staqe medical device company dedicated to creating new therapies that directly target the nerves of neurally-mediated peripheral and vicseral disease. …See details»
Tulavi Therapeutics - LinkedIn
Tulavi Therapeutics is a privately held company, developing a portfolio of innovative nerve repair products. Tulavi’s innovative Adaptive Hydrogel Technology is engineered to support nerve ...See details»
Tulavi Therapeutics' Leadership Team Team - The Org
The leadership team at Tulavi Therapeutics has a wealth of experience in both the medical and business industries. The team's founder has experience leading a medical device company …See details»
Tulavi Therapeutics - Facebook
Tulavi Therapeutics. 7 likes. Tulavi Therapeutics is focused on engineering simple, elegant solutions for nerve injuries.See details»
Tulavi Therapeutics - Crunchbase
Tulavi Therapeutics is a medical device company that develops products to improve surgical care of peripheral nerve injury. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
allay™ Nerve Cap - Small Nerve Set 00860012518104 Medical …
Aug 13, 2024 Tulavi Therapeutics, Inc. › 00860012518104. Nerve guide, synthetic-polymer, bioabsorbable. Primary Device ID: 00860012518104: NIH Device Record Key: cf94d3f3-c875 …See details»
allay Nerve Cap - Tulavi Therapeutics
Introducing The first and only fully absorbable in situ forming technology designed to protect transected nerves, prevent axonal escape, and reduce the risk of neuroma formation. Unmet …See details»
Josh Vose, Tulavi Therapeutics - In Situ Forming Hydrogel
Apr 24, 2024 Josh Vose presented Tulavi Therapeutics at LSI USA ‘24 Emerging Medtech Summit.Tulavi is Advancing Peripheral Nerve Care. Their in situ forming hydrogel tec...See details»
FDA clears surgical hydrogel nerve cap for preventing phantom …
Jul 22, 2024 Tulavi Therapeutics has received a de novo clearance from the FDA for a surgical kit designed to help reduce long-term phantom limb pains among people who have had an …See details»
FDA clears surgical hydrogel nerve cap for preventing phantom …
Tulavi Therapeutics has received a de novo clearance from the FDA for a surgical kit designed to help reduce long-term phantom limb pains among people who have had an amputation. The …See details»